Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Staffing Giant ManpowerGroup Plunges to Annual Low Amid Analyst Concerns

Dieter Jaworski by Dieter Jaworski
October 21, 2025
in Analysis, Earnings, Industrial
0
ManpowerGroup Stock
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Despite reporting quarterly earnings that surpassed market expectations, ManpowerGroup shares have collapsed to their lowest point in twelve months. The catalyst for this dramatic decline was a jarring analyst action from JPMorgan Chase & Co., which triggered a significant sell-off and overshadowed the company’s positive earnings surprise.

JPMorgan’s Downgrade Sparks Market Panic

The investment bank JPMorgan sent shockwaves through the market on Tuesday by slashing its price target for ManpowerGroup. In a move that signaled deep-seated concerns, the firm reduced its target substantially from $52 to $42 per share. Although JPMorgan maintained its neutral rating on the stock, the aggressive downward revision was interpreted by investors as a strongly pessimistic signal. The immediate aftermath saw the equity plummet to $33.26, establishing a new 52-week low.

Strong Quarterly Performance Overlooked

The sell-off occurred in direct contrast to the staffing firm’s recent financial report, which on the surface provided reasons for optimism. For the third quarter, ManpowerGroup posted adjusted earnings of $0.83 per share, exceeding the $0.81 per share forecast by analysts. Revenue also beat estimates, coming in at $4.63 billion.

Nevertheless, the market reaction was decisively negative, with the stock shedding more than 6% on the day the results were released. This indicates that investors are prioritizing long-term, structural anxieties within the staffing industry over short-term financial outperformance.

Should investors sell immediately? Or is it worth buying ManpowerGroup?

Divergent Regional and Segment Performance

A closer look at the operational results reveals a mixed picture. The company’s core Manpower brand demonstrated modest organic growth of 3%. However, this was counterbalanced by sharp declines in its specialized divisions, Experis and Talent Solutions, which fell by 7% and 8% respectively.

On a more promising note, the newly launched AI platform business is already making a meaningful contribution, accounting for 30% of new client revenue. Geographically, operations in North America and Europe are showing initial signs of stabilization, while demand remains robust in the Latin America and Asia-Pacific regions.

Profitability Metrics Fuel Investor Worry

Underlying the top-line figures, profitability remains a primary concern for stakeholders. Adjusted EBITDA witnessed a significant 22% drop to $96 million, compressing the margin to a thin 2.1%. Furthermore, the gross profit margin declined to 16.6%, a trend the company attributes to a reduction in permanent placement fees and ongoing shifts in its service model.

Looking ahead, ManpowerGroup has provided fourth-quarter earnings guidance in a range of $0.78 to $0.88 per share, a figure that includes currency translation effects. The central question for the market is whether this forecast will be sufficient to restore shaken investor confidence.

Ad

ManpowerGroup Stock: Buy or Sell?! New ManpowerGroup Analysis from February 8 delivers the answer:

The latest ManpowerGroup figures speak for themselves: Urgent action needed for ManpowerGroup investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 8.

ManpowerGroup: Buy or sell? Read more here...

Tags: ManpowerGroup
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

DroneShield Stock
Analysis

DroneShield Shares Face Headwinds Despite Record Performance

February 8, 2026
Rock Tech Lithium Stock
Analysis

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026
Puma Biotechnology Stock
Earnings

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

February 8, 2026
Next Post
Marvell Technology Stock

Chip Sector Faces Pressure as Marvell Technology Downgraded

Intel Stock

Intel's Critical Juncture: Can the Chipmaker Sustain Its Resurgence?

MicroStrategy Stock

MicroStrategy Doubles Down on Bitcoin Strategy Amid Market Volatility

Recommended

Cardano Stock

Cardano at a Crossroads: Navigating Critical Support Levels Amid Major Developments

3 months ago
Tesla Stock

Tesla Stock: Musk’s $30B Payday Amid Customer Exodus

6 months ago
Oxford Lane Capital Stock

Oxford Lane Capital Implements Strategic Overhaul with Reverse Split and Buybacks

5 months ago
Ciena Stock

Ciena Shares Hit Record Peak Amid AI Infrastructure Surge

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Trending

DroneShield Stock
Analysis

DroneShield Shares Face Headwinds Despite Record Performance

by Jackson Burston
February 8, 2026
0

A significant disconnect has emerged for DroneShield Ltd. The counter-drone technology company posted explosive growth for fiscal...

Rock Tech Lithium Stock

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026
Puma Biotechnology Stock

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

February 8, 2026
Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • DroneShield Shares Face Headwinds Despite Record Performance
  • Rock Tech Lithium: Investors Await the Final Go-Ahead
  • Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com